Home Onxeo: Belinostat Phase I/II Results in Soft Tissue Sarcoma to Be...
 

Keywords :   


Onxeo: Belinostat Phase I/II Results in Soft Tissue Sarcoma to Be...

2015-04-10 00:14:21| Logistics - Topix.net

PARIS & COPENHAGEN, Denmark-- -- Regulatory News: Onxeo S.A. , an innovative company specializing in the development of orphan oncology drugs, today announced that the phase I/II clinical trial of belinostat in combination with doxorubicin in patients with soft tissue sarcoma was accepted for presentation in the Poster Discussion Session at the 2015 Annual Meeting of the American Society of Clinical Oncology , taking place in Chicago, USA from May 29 to June 2, 2015. The PXD101-CLN-14 study was an open -label, multicenter, dose-escalation phase I/II to evaluate the safety and efficacy of the combination of belinostat with doxorubicin in patients with advanced solid tumors and STS .

Tags: to results iii soft

Category:Transportation and Logistics

Latest from this category

All news

01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Eastern North Pacific Tropical Weather Outlook
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
Transportation and Logistics »
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
01.11BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
More »